Head, Division of Cellular and Molecular Research, National Cancer Center Singapore Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute of Molecular Pathology in Vienna, Austria, he moved to…...
Ruggero De Maria, M.D.
President, Alliance Against Cancer; Director, Institute of Pathology, Catholic University, Rome, Italy Professor Ruggero De Maria obtained his M.D. at the University of Catania (1989) and completed his residence training in endocrinology at the University of Palermo (1994). During his postdoc at the Department of Experimental Medicine, University of Rome,…...
Webster Cavenee, Ph.D.
Director of Strategic Alliances, Ludwig Institute for Cancer Research Distinguished Professor of Medicine, University of California San Diego Dr. Cavenee did his graduate and postdoctoral training in cell biology, biochemistry and human genetics. He received his Ph.D. with honors in 1977 from the University of Kansas Medical School and then…...
Alfred Slanetz, Ph.D.
Chairman of the Board Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since its incorporation in 2012. Geneius, an immuno-oncology start-up, is researching ways to help cancer patients’ immune…...









